What are the major opportunities in the Dry Age Related Macular Degeneration (AMD) market? What are the strategies for the Dry Age Related Macular Degeneration (AMD) market?

For detailed insights on the major opportunities and strategies in the Dry Age Related Macular Degeneration (AMD) market, Read More

How does the Dry Age Related Macular Degeneration (AMD) market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Dry Age Related Macular Degeneration (AMD) market growth and SWOT analysis of the Dry Age Related Macular Degeneration (AMD) industry, Read More

Dry Age Related Macular Degeneration (AMD) Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Dry Age Related Macular Degeneration (AMD) Market Report 2026

Name: Dry Age Related Macular Degeneration (AMD) Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Stages (Early Age-Related Macular Degeneration, Intermediate Age-Related Macular Degeneration, Late Age-Related Macular Degeneration), By Age Group (Above 75 Years, Above 60 Years, Above 40 Years), By Route Of Administration (Oral, Injectables), By End Users (Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Dry Age Related Macular Degeneration (AMD) Market Overview

• Dry Age Related Macular Degeneration (AMD) market size has reached to $4.89 billion in 2025

• Expected to grow to $7.36 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%

• Growth Driver: Rising Geriatric Population To Drive The Market Growth

• Market Trend: Advancements In Dry AMD Treatment Lumithera's Valeda Light Delivery System

• North America was the largest region in 2025.

What Is Covered Under Dry Age Related Macular Degeneration (AMD) Market?

Dry age related macular degeneration (AMD) refers to a progressive eye condition characterized by the gradual deterioration of the macula, the central part of the retina, leading to blurred central vision. They are used for managing and slowing the progression of the disease through treatments like vitamins, nutritional supplements, and emerging pharmaceutical therapies.

The main stages are the dry age related macular degeneration (AMD) of early age-related macular degeneration, intermediate age-related macular degeneration, and late age-related macular degeneration. Early age-related macular degeneration (AMD) is the initial stage of a common eye condition that primarily affects older adults, causing changes in the retina, specifically the macula, which is responsible for central vision. It will attack in different age groups, such as above 75 years, above 60 years, and above 40 years. They treated various routes of administration, oral and injectables, and this is using various end users, like hospitals and clinics, diagnostic centers, and academic and research institutes.

Dry Age Related Macular Degeneration (AMD) Market Global Report 2026 Market Report bar graph

What Is The Dry Age Related Macular Degeneration (AMD) Market Size and Share 2026?

The dry age related macular degeneration (amd) market size has grown strongly in recent years. It will grow from $4.89 billion in 2025 to $5.32 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to aging population growth, ophthalmology clinic expansion, vitamin-based therapy adoption, retinal imaging advancements, vision loss awareness.

What Is The Dry Age Related Macular Degeneration (AMD) Market Growth Forecast?

The dry age related macular degeneration (amd) market size is expected to see strong growth in the next few years. It will grow to $7.36 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to novel therapeutic pipeline development, precision ophthalmology, ai-based retinal diagnostics, preventive eye care programs, clinical trial investments. Major trends in the forecast period include growing focus on early disease detection, increased use of nutritional supplement therapies, expansion of research on disease-modifying drugs, rising adoption of advanced retinal imaging, increasing patient awareness and screening.

Book your 30 minutes free consultation with our research experts

Global Dry Age Related Macular Degeneration (AMD) Market Segmentation

1) By Stages: Early Age-Related Macular Degeneration, Intermediate Age-Related Macular Degeneration, Late Age-Related Macular Degeneration

2) By Age Group: Above 75 Years, Above 60 Years, Above 40 Years

3) By Route Of Administration: Oral, Injectables

4) By End Users: Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes

Subsegments:

1) By Early Age-Related Macular Degeneration: Drusen Accumulation, Retinal Pigment Epithelium Changes

2) By Intermediate Age-Related Macular Degeneration: Larger Drusen Deposits, Increased Pigmentary Abnormalities

3) By Late Age-Related Macular Degeneration: Geographic Atrophy, Central Vision Loss

What Is The Driver Of The Dry Age Related Macular Degeneration (AMD) Market?

The growing geriatric population is expected to propel the growth of the dry age-related macular degeneration (AMD) market going forward. The geriatric population refers to individuals aged 65 years and older who experience age-related physiological changes that increase their need for healthcare and vision-care services. The geriatric population is rising due to increased life expectancy, improved chronic-disease management, advancements in medical technology, and expanded access to geriatric care worldwide. The dry age-related macular degeneration (AMD) supports this trend by offering targeted therapies and management solutions that help slow retinal degeneration and preserve vision among older adults. For instance, in July 2023, according to the United Nations, a US-based intergovernmental organization, the global population aged 65 years and older reached 0.77 billion in 2022 and is projected to approach 1.0 billion by 2030. Therefore, the growing geriatric population is driving the growth of the dry age-related macular degeneration (AMD) market.

Key Players In The Global Dry Age Related Macular Degeneration (AMD) Market

Major companies operating in the dry age related macular degeneration (amd) market are F Hoffmann-La Roche Ltd., Novartis AG, Bayer AG, Amgen Inc., Biogen Inc., Astellas Pharma Inc., Bausch Health Companies Inc., Lupin Ltd., Santen Pharmaceuticals Inc., Biocon Ltd., Apellis Pharmaceuticals Inc., Belite Bio Inc., Alkeus Pharmaceuticals Inc., Ribomic Inc., Eyestem Research Pvt. Ltd., LumiThera Inc., Adverum Biotechnologies Inc., Regeneron Pharmaceuticals Inc., Annexon Biosciences Inc., Stealth BioTherapeutics Corp., Kodiak Sciences Inc., Ionis Pharmaceuticals Inc., Lineage Cell Therapeutics Inc., Ocular Therapeutix Inc.

Global Dry Age Related Macular Degeneration (AMD) Market Trends and Insights

Major companies operating in the dry age-related macular degeneration (AMD) market are focusing on developing advanced technologies such as light delivery systems to activate retinal cells, improve visual function, and potentially slow disease progression. Light delivery systems refer to therapeutic devices designed to deliver controlled wavelengths of light to targeted retinal tissues, stimulating cellular activity and supporting retinal health through non-invasive photobiomodulation techniques. For instance, in January 2024, LumiThera Inc., a US-based medical device company, launched photobiomodulation therapy for dry AMD using the Valeda Light Delivery System, the first FDA-authorized treatment for vision loss associated with dry AMD. The system utilizes a multi-wavelength light delivery approach employing 590 nm, 660 nm, and 850 nm wavelengths to stimulate retinal cells, and LumiThera has initiated the EUROLIGHT registry study to collect long-term outcome data, with treatments typically administered in nine sessions over a three- to four-week period.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Dry Age Related Macular Degeneration (AMD) Market?

In May 2023, Astellas Pharma Inc., a Japan-based pharmaceutical company, acquired IVERIC Bio Inc. for $5.9 billion. Through this acquisition, Astellas Pharma aims to expand its presence in the ophthalmology market by accelerating the development of novel treatments for retinal diseases and improving outcomes for patients worldwide. IVERIC Bio Inc. is a US-based biotechnology company that develops drugs and therapies for age-related macular degeneration and other retinal conditions.

Regional Outlook

North America was the largest region in the dry age-related macular degeneration (AMD) market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Dry Age Related Macular Degeneration (AMD) Market?

The dry age related macular degeneration (AMD) market consists of sales of syfovre, zimura, visudyne, and alk-001. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Dry Age Related Macular Degeneration (AMD) Market Report 2026?

The dry age related macular degeneration (amd) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the dry age related macular degeneration (amd) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Dry Age Related Macular Degeneration (AMD) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$5.32 billion
Revenue Forecast In 2035	$7.36 billion
Growth Rate	CAGR of 8.8% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Stages, Age Group, Route Of Administration, End Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	F Hoffmann-La Roche Ltd., Novartis AG, Bayer AG, Amgen Inc., Biogen Inc., Astellas Pharma Inc., Bausch Health Companies Inc., Lupin Ltd., Santen Pharmaceuticals Inc., Biocon Ltd., Apellis Pharmaceuticals Inc., Belite Bio Inc., Alkeus Pharmaceuticals Inc., Ribomic Inc., Eyestem Research Pvt. Ltd., LumiThera Inc., Adverum Biotechnologies Inc., Regeneron Pharmaceuticals Inc., Annexon Biosciences Inc., Stealth BioTherapeutics Corp., Kodiak Sciences Inc., Ionis Pharmaceuticals Inc., Lineage Cell Therapeutics Inc., Ocular Therapeutix Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Dry Age Related Macular Degeneration (AMD) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Dry Age Related Macular Degeneration (AMD) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Dry Age Related Macular Degeneration (AMD) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Dry Age Related Macular Degeneration (AMD) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Growing Focus On Early Disease Detection

4.2.2 Increased Use Of Nutritional Supplement Therapies

4.2.3 Expansion Of Research On Disease-Modifying Drugs

4.2.4 Rising Adoption Of Advanced Retinal Imaging

4.2.5 Increasing Patient Awareness And Screening

5. Dry Age Related Macular Degeneration (AMD) Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Ophthalmology Centers

5.3 Diagnostic Centers

5.4 Academic And Research Institutes

5.5 Specialty Eye Care Clinics

6. Dry Age Related Macular Degeneration (AMD) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Dry Age Related Macular Degeneration (AMD) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Dry Age Related Macular Degeneration (AMD) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Dry Age Related Macular Degeneration (AMD) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Dry Age Related Macular Degeneration (AMD) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Dry Age Related Macular Degeneration (AMD) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Dry Age Related Macular Degeneration (AMD) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Dry Age Related Macular Degeneration (AMD) Market Segmentation

9.1. Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Early Age-Related Macular Degeneration, Intermediate Age-Related Macular Degeneration, Late Age-Related Macular Degeneration

9.2. Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Above 75 Years, Above 60 Years, Above 40 Years

9.3. Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Injectables

9.4. Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes

9.5. Global Dry Age Related Macular Degeneration (AMD) Market, Sub-Segmentation Of Early Age-Related Macular Degeneration, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Drusen Accumulation, Retinal Pigment Epithelium Changes

9.6. Global Dry Age Related Macular Degeneration (AMD) Market, Sub-Segmentation Of Intermediate Age-Related Macular Degeneration, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Larger Drusen Deposits, Increased Pigmentary Abnormalities

9.7. Global Dry Age Related Macular Degeneration (AMD) Market, Sub-Segmentation Of Late Age-Related Macular Degeneration, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Geographic Atrophy, Central Vision Loss

10. Dry Age Related Macular Degeneration (AMD) Market Regional And Country Analysis

10.1. Global Dry Age Related Macular Degeneration (AMD) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Dry Age Related Macular Degeneration (AMD) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Dry Age Related Macular Degeneration (AMD) Market

11.1. Asia-Pacific Dry Age Related Macular Degeneration (AMD) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Dry Age Related Macular Degeneration (AMD) Market

12.1. China Dry Age Related Macular Degeneration (AMD) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Dry Age Related Macular Degeneration (AMD) Market

13.1. India Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Dry Age Related Macular Degeneration (AMD) Market

14.1. Japan Dry Age Related Macular Degeneration (AMD) Market Overview

14.2. Japan Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Dry Age Related Macular Degeneration (AMD) Market

15.1. Australia Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Dry Age Related Macular Degeneration (AMD) Market

16.1. Indonesia Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Dry Age Related Macular Degeneration (AMD) Market

17.1. South Korea Dry Age Related Macular Degeneration (AMD) Market Overview

17.2. South Korea Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Dry Age Related Macular Degeneration (AMD) Market

18.1. Taiwan Dry Age Related Macular Degeneration (AMD) Market Overview

18.2. Taiwan Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Dry Age Related Macular Degeneration (AMD) Market

19.1. South East Asia Dry Age Related Macular Degeneration (AMD) Market Overview

19.2. South East Asia Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Dry Age Related Macular Degeneration (AMD) Market

20.1. Western Europe Dry Age Related Macular Degeneration (AMD) Market Overview

20.2. Western Europe Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Dry Age Related Macular Degeneration (AMD) Market

21.1. UK Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Dry Age Related Macular Degeneration (AMD) Market

22.1. Germany Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Dry Age Related Macular Degeneration (AMD) Market

23.1. France Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Dry Age Related Macular Degeneration (AMD) Market

24.1. Italy Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Dry Age Related Macular Degeneration (AMD) Market

25.1. Spain Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Dry Age Related Macular Degeneration (AMD) Market

26.1. Eastern Europe Dry Age Related Macular Degeneration (AMD) Market Overview

26.2. Eastern Europe Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Dry Age Related Macular Degeneration (AMD) Market

27.1. Russia Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Dry Age Related Macular Degeneration (AMD) Market

28.1. North America Dry Age Related Macular Degeneration (AMD) Market Overview

28.2. North America Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Dry Age Related Macular Degeneration (AMD) Market

29.1. USA Dry Age Related Macular Degeneration (AMD) Market Overview

29.2. USA Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Dry Age Related Macular Degeneration (AMD) Market

30.1. Canada Dry Age Related Macular Degeneration (AMD) Market Overview

30.2. Canada Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Dry Age Related Macular Degeneration (AMD) Market

31.1. South America Dry Age Related Macular Degeneration (AMD) Market Overview

31.2. South America Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Dry Age Related Macular Degeneration (AMD) Market

32.1. Brazil Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Dry Age Related Macular Degeneration (AMD) Market

33.1. Middle East Dry Age Related Macular Degeneration (AMD) Market Overview

33.2. Middle East Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Dry Age Related Macular Degeneration (AMD) Market

34.1. Africa Dry Age Related Macular Degeneration (AMD) Market Overview

34.2. Africa Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Segmentation By Age Group, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Dry Age Related Macular Degeneration (AMD) Market Regulatory and Investment Landscape

36. Dry Age Related Macular Degeneration (AMD) Market Competitive Landscape And Company Profiles

36.1. Dry Age Related Macular Degeneration (AMD) Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Dry Age Related Macular Degeneration (AMD) Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Dry Age Related Macular Degeneration (AMD) Market Company Profiles

36.3.1. F Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Dry Age Related Macular Degeneration (AMD) Market Other Major And Innovative Companies

Astellas Pharma Inc., Bausch Health Companies Inc., Lupin Ltd., Santen Pharmaceuticals Inc., Biocon Ltd., Apellis Pharmaceuticals Inc., Belite Bio Inc., Alkeus Pharmaceuticals Inc., Ribomic Inc., Eyestem Research Pvt. Ltd., LumiThera Inc., Adverum Biotechnologies Inc., Regeneron Pharmaceuticals Inc., Annexon Biosciences Inc., Stealth BioTherapeutics Corp.

38. Global Dry Age Related Macular Degeneration (AMD) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Dry Age Related Macular Degeneration (AMD) Market

40. Dry Age Related Macular Degeneration (AMD) Market High Potential Countries, Segments and Strategies

40.1 Dry Age Related Macular Degeneration (AMD) Market In 2030 - Countries Offering Most New Opportunities

40.2 Dry Age Related Macular Degeneration (AMD) Market In 2030 - Segments Offering Most New Opportunities

40.3 Dry Age Related Macular Degeneration (AMD) Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Dry Age Related Macular Degeneration (AMD) Market, Overview Of Key Products - Product Examples

Table 2: Global Dry Age Related Macular Degeneration (AMD) Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Dry Age Related Macular Degeneration (AMD) Market, Supply Chain Analysis

Table 4: Global Dry Age Related Macular Degeneration (AMD) Market, Major Raw Material Providers

Table 5: Global Dry Age Related Macular Degeneration (AMD) Market, Major Resource Providers

Table 6: Global Dry Age Related Macular Degeneration (AMD) Market, Major Manufacturers (Suppliers)

Table 7: Global Dry Age Related Macular Degeneration (AMD) Market, Major Distributors And Channel Partners

Table 8: Global Dry Age Related Macular Degeneration (AMD) Market, Key Technologies & Future Trends

Table 9: Global Dry Age Related Macular Degeneration (AMD) Market, Major Trends

Table 10: Global Dry Age Related Macular Degeneration (AMD) Market, Major End Users

Table 11: Global Dry Age Related Macular Degeneration (AMD) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Dry Age Related Macular Degeneration (AMD) Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Dry Age Related Macular Degeneration (AMD) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Dry Age Related Macular Degeneration (AMD) Market - TAM, US$ Billion, 2025

Table 15: Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Dry Age Related Macular Degeneration (AMD) Market, Sub-Segmentation Of Early Age-Related Macular Degeneration, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Dry Age Related Macular Degeneration (AMD) Market, Sub-Segmentation Of Intermediate Age-Related Macular Degeneration, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Dry Age Related Macular Degeneration (AMD) Market, Sub-Segmentation Of Late Age-Related Macular Degeneration, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Dry Age Related Macular Degeneration (AMD) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Dry Age Related Macular Degeneration (AMD) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Dry Age Related Macular Degeneration (AMD) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Dry Age Related Macular Degeneration (AMD) Market - Company Scoring Matrix

Table 98: F Hoffmann-La Roche Ltd. Financial Performance

Table 99: Novartis AG Financial Performance

Table 100: Bayer AG Financial Performance

Table 101: Amgen Inc. Financial Performance

Table 102: Biogen Inc. Financial Performance

Table 103: Global Dry Age Related Macular Degeneration (AMD) Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Dry Age Related Macular Degeneration (AMD) Market, Competitive Dashboard

Table 105: Global Dry Age Related Macular Degeneration (AMD) Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Dry Age Related Macular Degeneration (AMD) Market Size Gain ($ Billion), Segmentation By Stages, 2025 – 2030

Table 107: Global, Dry Age Related Macular Degeneration (AMD) Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

Table 108: Global, Dry Age Related Macular Degeneration (AMD) Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

Figure 1: Global Dry Age Related Macular Degeneration (AMD) Market, Overview Of Key Products - Product Examples

Figure 2: Global Dry Age Related Macular Degeneration (AMD) Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Dry Age Related Macular Degeneration (AMD) Market, Supply Chain Analysis

Figure 4: Global Dry Age Related Macular Degeneration (AMD) Market, Major Raw Material Providers

Figure 5: Global Dry Age Related Macular Degeneration (AMD) Market, Major Resource Providers

Figure 6: Global Dry Age Related Macular Degeneration (AMD) Market, Major Manufacturers (Suppliers)

Figure 7: Global Dry Age Related Macular Degeneration (AMD) Market, Major Distributors And Channel Partners

Figure 8: Global Dry Age Related Macular Degeneration (AMD) Market, Key Technologies & Future Trends

Figure 9: Global Dry Age Related Macular Degeneration (AMD) Market, Major Trends

Figure 10: Global Dry Age Related Macular Degeneration (AMD) Market, Major End Users

Figure 11: Global Dry Age Related Macular Degeneration (AMD) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Dry Age Related Macular Degeneration (AMD) Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Dry Age Related Macular Degeneration (AMD) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Dry Age Related Macular Degeneration (AMD) Market - TAM, US$ Billion, 2025

Figure 15: Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Dry Age Related Macular Degeneration (AMD) Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Dry Age Related Macular Degeneration (AMD) Market, Sub-Segmentation Of Early Age-Related Macular Degeneration, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Dry Age Related Macular Degeneration (AMD) Market, Sub-Segmentation Of Intermediate Age-Related Macular Degeneration, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Dry Age Related Macular Degeneration (AMD) Market, Sub-Segmentation Of Late Age-Related Macular Degeneration, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Dry Age Related Macular Degeneration (AMD) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Dry Age Related Macular Degeneration (AMD) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Stages, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Dry Age Related Macular Degeneration (AMD) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Dry Age Related Macular Degeneration (AMD) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Dry Age Related Macular Degeneration (AMD) Market - Company Scoring Matrix

Figure 98: F Hoffmann-La Roche Ltd. Financial Performance

Figure 99: Novartis AG Financial Performance

Figure 100: Bayer AG Financial Performance

Figure 101: Amgen Inc. Financial Performance

Figure 102: Biogen Inc. Financial Performance

Figure 103: Global Dry Age Related Macular Degeneration (AMD) Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Dry Age Related Macular Degeneration (AMD) Market, Competitive Dashboard

Figure 105: Global Dry Age Related Macular Degeneration (AMD) Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Dry Age Related Macular Degeneration (AMD) Market Size Gain ($ Billion), Segmentation By Stages, 2025 – 2030

Figure 107: Global, Dry Age Related Macular Degeneration (AMD) Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

Figure 108: Global, Dry Age Related Macular Degeneration (AMD) Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Macular Degeneration Treatment Market Report 2026 - Global Outlook – By Stage of Disease (Early-Stage AMD, Intermediate AMD, Late-Stage AMD), By Route of Administration (Oral, Injectable, Other Routes of Administration),...

Macular Edema and Macular Degeneration Market Report 2026 - Global Outlook – By Treatment Type (Drug Therapy, Laser Treatment), By Application (Macular Edema, Diabetic Macular Edema (DME), Cystoid Macular Edema (CME), Ma...

Non-Proliferative Diabetic Retinopathy Market Report 2026 - Global Outlook – By Treatment Type (Anti-Vascular Endothelial Growth Factor (VEGF) Therapy, Intraocular Steroid Injection, Laser Surgery, Vitrectomy), By Diseas...

Dry Eye Syndrome Market Report 2026 - Global Outlook – By Product (Liquid Drops, Gel, Liquid Wipes, Eye Ointment, Other Products), By Treatment (Corticosteroids, Artificial Tears, Oral Omega Supplements, Lubricating Agen...

Retinal Disorder Treatment Market Report 2026 - Global Outlook – By Type (Macular Degeneration, Diabetic Retinopathy, Other Types), By Dosage Form (Gels, Eye Solutions, Capsules And Tablets, Eye Drops, Ointments), By Dis...

Retinal Biologics Market Report 2026 - Global Outlook – By Drug Class (Vascular Endothelial Growth Factor (VEGF)-A Antagonist, Tumor Necrosis Factor (TNF)-A Inhibitor), By Indication (Macular Degeneration, Diabetic Retin...

Diabetic Retinopathy Market Report 2026 - Global Outlook – By Type (Proliferative Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy), By Treatment (Anti-VEGF Drugs, Intraocular Steroid Injection, Laser Photoco...

Frequently Asked Questions

How big is the Dry Age Related Macular Degeneration (AMD) Market?

The Dry Age Related Macular Degeneration (AMD) market was valued at $4.89 billion in 2025, increased to $5.32 billion in 2026, and is projected to reach $7.36 billion by 2030.

What is the Dry Age Related Macular Degeneration (AMD) market growth?

The global Dry Age Related Macular Degeneration (AMD) market is expected to grow at a CAGR of 8.5% from 2026 to 2035 to reach $7.36 billion by 2035.

Who are the key players in Dry Age Related Macular Degeneration (AMD) market?

Some Key Players in the Dry Age Related Macular Degeneration (AMD) market Include, F Hoffmann-La Roche Ltd., Novartis AG, Bayer AG, Amgen Inc., Biogen Inc., Astellas Pharma Inc., Bausch Health Companies Inc., Lupin Ltd., Santen Pharmaceuticals Inc., Biocon Ltd., Apellis Pharmaceuticals Inc., Belite Bio Inc., Alkeus Pharmaceuticals Inc., Ribomic Inc., Eyestem Research Pvt. Ltd., LumiThera Inc., Adverum Biotechnologies Inc., Regeneron Pharmaceuticals Inc., Annexon Biosciences Inc., Stealth BioTherapeutics Corp., Kodiak Sciences Inc., Ionis Pharmaceuticals Inc., Lineage Cell Therapeutics Inc., Ocular Therapeutix Inc. .

What is the anticipated growth trend for the Dry Age Related Macular Degeneration (AMD) market?

Major trend in this market includes: Advancements In Dry AMD Treatment Lumithera's Valeda Light Delivery System. For further insights on this market. request a sample here

Which region has the most growth potential in the Dry Age Related Macular Degeneration (AMD) market?

North America was the largest region in the dry age-related macular degeneration (AMD) market in 2025. The regions covered in the dry age related macular degeneration (amd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.